Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
about
External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology.Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0HIV-1 viral load assays for resource-limited settings.Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasmaDeterminations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.International multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasmaQuantitation of human immunodeficiency virus type 1 RNA in different biological compartments.Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and OAbsolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.Current practices in laboratory monitoring of HIV infection.Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles.Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.Principles and applications of polymerase chain reaction in medical diagnostic fields: a review.Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators.Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyClinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasmaReproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasmaDesign and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target.Multicenter proficiency testing of nucleic acid amplification methods for the detection of enteroviruses.Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.
P2860
Q27471433-5D635096-0908-4FC2-A247-7A042E6BFAD6Q28364015-A817E521-E91F-4692-8211-1D8A4B496004Q33259966-C2461019-DCDA-4CCC-926A-49ED4DC9C296Q33660617-A764FDD6-823A-426A-8908-23B0986EC2D1Q33668265-CA7A8565-1EDC-43B1-8A12-7BAF87D556E6Q33963580-5E89F6E6-8AFC-42E0-9468-73396C385599Q33966350-FF51B137-339E-4E8B-86F2-5428FD4FDFFDQ33971897-4102E290-551B-4535-A94D-F2A0EB29C33CQ34073785-6BD712D2-4DAD-4B7E-9FBF-9C893299A3C5Q34328792-8816AADC-7E2C-4227-8AFC-D787916BDCF4Q35770853-C596E42C-5838-4711-A506-2DFF39ABBDC8Q36548250-F1C4FAE8-2D99-476E-87A7-CE51293A15F2Q36783073-E05BE2E9-961E-44FE-850B-42624C3E2A35Q37159312-E99AD1E5-6541-4271-BE22-CA9ACBB88C51Q37240930-3C3056B6-4EF9-400F-BCF0-C7FE0FEC9F86Q39443872-92C469C6-BD69-4661-9C18-73E44026A34AQ39446249-2954E5E2-3EB9-4961-BB2D-E09227E256ACQ39447554-E7310233-D55F-4614-99D4-F28BE5E3F4AEQ39449534-99AC182D-5D86-440C-ADF1-0CF627ACA947Q39466276-BAA66820-3A80-4060-859E-E72BEF7DADF1Q39467920-3967EBB2-C6FF-4A75-9E5F-463501DD94D4Q39552641-5BF5F1BC-99A0-4326-BD3E-6776EE1A3764Q39556258-6AE7CBC9-8057-45F3-BA36-25D48C6C53EDQ42728263-D31CDAD4-DB5E-417A-99D1-1A02F8D47D58
P2860
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@ast
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@en
type
label
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@ast
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@en
prefLabel
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@ast
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@en
P2093
P2860
P1476
Multicenter comparison of thre ...... cy virus type 1 RNA in plasma.
@en
P2093
Boucher CA
Brun-Vezinet F
Descamps D
Schuurman R
Tijnagel J
Weverling GJ
Williams I
P2860
P304
P407
P577
1996-12-01T00:00:00Z